WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Former Connecticut budget official arrested, pleads not guilty to bribery and extortion charges
Movie Review: ‘STEVE! (martin)’ looks at past, present in a lovely, intimate 2
Project to shore up Pompeii yields stunning black banquet hall, with frescoes of Trojan War figures
Cannes sets lineup with Lanthimos, Coppola and Trump film 'The Apprentice'
Scottie Scheffler arrested at PGA Championship, returns to course
Scientists tinker with evolution to save Hawaii coral reefs
Scientists tinker with evolution to save Hawaii coral reefs
2025 Oscars: Academy Awards announces March 2 date
Biden marks Brown v. Board of Education anniversary amid signs of erosion in Black voter support
Jailed Vietnamese dissident Pham Doan Trang to be honored by PEN America
Hush money trial: Trump asks New York court to intervene in fight over gag order
Bakery outlets close across New England and New York